BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Ophthalmology 2005;89:1522-1528; doi:10.1136/bjo.2005.074716
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, W-M
Right arrow Articles by Lam, D S C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, W-M
Right arrow Articles by Lam, D S C

PERSPECTIVE

Choroidal neovascularisation in pathological myopia: an update in management

W-M Chan1,2, M Ohji3, T Y Y Lai1, D T L Liu2, Y Tano3, D S C Lam1,2

1 Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, People’s Republic of China
2 Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, People’s Republic of China
3 Department of Ophthalmology, Osaka University Medical School, Osaka, Japan

Correspondence to:
Correspondence to:
Professor Wai-Man Chan
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon, Hong Kong; cwm6373{at}netvigator.com

Choroidal neovascularisation (CNV) secondary to pathological myopia is an important cause of significant visual impairment in young and middle aged adults globally and is particularly prevalent in Asian populations. In the past few years, there have been rapid advancements in the different treatments for myopic CNV. The purpose of this perspective is to give an overview of the natural history of myopic CNV and the various treatment options including laser photocoagulation, photodynamic therapy, submacular surgery, and macular translocation surgery. Future directions in the management of myopic CNV are also discussed.


Abbreviations: AMD, age related macular degeneration; CNV, choroidal neovascularisation; FA, fluorescein angiography; ICG-A, indocyanine green angiography; LMT, limited macular translocation; MfERG, multifocal electroretinogram; OCT, optical coherence tomography; RPE, retinal pigment epithelium; VA, visual acuity; VEGF, vascular endothelial growth factor

Keywords: myopia; choroidal neovascularisation; photodynamic therapy; surgery; macular translocation




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
P J Rosenfeld
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues
Br. J. Ophthalmol., February 1, 2007; 91(2): 128 - 130.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
W.-M. Chan, T. Y Y Lai, A. L Wong, D. T L Liu, and D. S C Lam
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Br. J. Ophthalmol., February 1, 2007; 91(2): 174 - 179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.